PhD positions available within our group: 7th January 2019 deadline
A number of PhD positions are available within the group.
Funding will be allocated to successful applicants rather, than project. Successful applicant will receive tuition fees(UK/EU) paid and a stipend (for UK residents only).
Closing date for all applications is 7th January 2019 with interviews being scheduled for February 2019.
Dr Garry Laverty (First supervisor) and Professor Karl Malcolm: Peptide hydrogels as a long-acting multipurpose drug delivery platform for combined contraception and HIV prevention
Dr Irina Tikhonova and Dr Garry Laverty (second supervisor) – Rational design of novel peptide hydrogels for drug delivery
More details can be found at the School of Pharmacy link below:
Feel free to contact us if any questions about the projects or our work.
Advanced Science News Coverage and Advanced Healthcare Materials paper
Our recent research into using peptide hydrogels as long-acting injectable implants for HIV/AIDS drug delivery has be covered by Advanced Science News. This provides an oversight of our most recent publication within Advanced Healthcare Materials. A link to both can be found below: Advanced Science News Advanced Healthcare Materials
Our EPSRC research selected as case study
Our research into long-acting peptide hydrogel drug delivery implants has been selected as a case study by the EPSRC for their Developing New Therapies Grand Challenge. Thanks to all of those involved in this multidisciplinary project and it’s great to see our work moving forward towards future use in patients. Please find a link to the […]
Get your tickets for the NI Science Festival: Gel Jabs: How Pioneering Hydrogels Fight Infection and Disease
We will be presenting a talk on how we are researching our peptide hydrogels as future medicines at the NI Science Saturday on 25th February 2023 (11 – 12pm) in Lecture Theatre 2, Medical Biology Centre (Queen’s University Belfast, 97 Lisburn Road, Belfast, BT9 7BL). Click here to get your tickets All are welcome to this […]
Research Group receive Innovate UK ICURe SETsquared Award
We are delighted to be currently taking part in the UKRI Innovate UK ICURe SETsquared Cohort 32 (32-08 / 520268133: £30,000). This programme is allowing us to market validate our peptide hydrogel technology in a variety of applications both within drug delivery and the wider commercial landscape. Our Research Associate Simon Porter is currently undertaking these […]
2021 Soft Matter Emerging Investigators: Unravelling the antimicrobial activity of peptide hydrogel systems: current and future perspectives
Our latest review paper has been published in the 2021 Soft Matter Emerging Investigators issue. If you have an interest in peptide hydrogels or hydrogels within antimicrobial applications then please do check it out here! We should hopefully have some exciting data to publish in this area in the coming months.